NL-OMON35263已完成不适用
*Diabetes and vascular complications: normoxia versus hypoxia* - DM-Hypoxia
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Diagnosed with type 2 diabetes mellitus at least 2 years ago
排除标准
- •- Cardiovascular disease
- •- Hypercholesterolemia and/or subjects on cholesterol-lowering drugs
- •- Hypertension (>160 mmHg systolic and/or >90 mmHg diastolic pressure) and/or subjects on antihypertensive drugs
- •- Type I diabetes mellitus
- •- Older than 65 years
- •- Subjects with vascular complications due to type 2 diabetes mellitus (e.g. diabetic foot ulcer)
研究者
相似试验
进行中（未招募）
不适用
Diabetes and vascular complications: the role of endothelin and physical inactivity’EUCTR2009-015602-18-NLActelion Pharmaceuticals
尚未招募
不适用
Study on complications of diabetes and risk of heart attackCTRI/2019/01/017120Osmania Medical College
已完成
不适用
Microvascular complications of diabetes mellitusmicrovascular complications in patients with diabetes type 1 and 2E14.3DRKS00007880niversitätsklinikum Heidelberg, Klinik für Endokrinologie, Stoffwechsel und Klinische Chemie502
进行中（未招募）
4 期
ASCEND PLUS - a research study to test whether a treatment called oral semaglutide can protect people with type 2 diabetes from heart attacks, strokes, and other health problemsISRCTN76193287niversity of Oxford20,000
已完成
不适用
Clinical benefit for diabetic vascular complication on non-invasive measurement of advanced glycogen endproduct level in type 2 diabetesType 2 DiabetesJPRN-UMIN000024756Human Ethics Review Committee of Kumamoto University600